BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2012


Naperville, IL -- (SBWire) -- 06/06/2012 --BioMarin Pharmaceutical - Product Pipeline Review 2012 provides data on the BioMarin Pharmaceutical Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, BioMarin Pharmaceutical Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from BioMarin Pharmaceutical Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.


- BioMarin Pharmaceutical Inc. - Brief BioMarin Pharmaceutical Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of BioMarin Pharmaceutical Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of BioMarin Pharmaceutical Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the BioMarin Pharmaceutical’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate BioMarin Pharmaceutical Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of BioMarin Pharmaceutical Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the BioMarin Pharmaceutical Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with BioMarin Pharmaceutical Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of BioMarin Pharmaceutical Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of BioMarin Pharmaceutical Inc.; BioMarin Pharmaceutical Inc. - Key Therapeutics; BioMarin Pharmaceutical Inc. - Pipeline Overview and Promising Molecules BioMarin Pharmaceutical Inc. - News; BioMarin Pharmaceutical Inc. - Latest Updates; BioMarin Pharmaceutical Inc. - Pipeline; BioMarin Pharmaceutical Inc. - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit:

Media Relations Contact

Web Master

View this press release online at: